Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,175Revenue $M0.0Net Margin (%)0Z-Score-7.8
Enterprise Value $M2,223EPS $-0.6Operating Margin %0F-Score4
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %-19.2Quick Ratio0.7Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-25.6Current Ratio0.7Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-77.3Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M406ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with MNKD

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MNKDJean-Marie Eveillard 2013-03-31 Sold Out -0.01%$2.31 - $3.56
($2.75)
$ 5.3695%Sold Out0
MNKDJean-Marie Eveillard 2012-12-31 Buy 0.01%$1.85 - $2.83
($2.16)
$ 5.36148%New holding, 800000 sh.800,000
MNKDGeorge Soros 2007-09-30 Sold Out -0.01%$8.87 - $13.09
($10.2)
$ 5.36-48%Sold Out0
MNKDGeorge Soros 2007-06-30 Buy 0.01%$11.46 - $14.95
($13.3)
$ 5.36-60%New holding, 13493 sh.13,493
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MNKD is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


MNKD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Palumbo DianeVice President, Human Resource 2014-12-01Sell183,522$5.89-9view
Edstrom HakanPresident & COO 2014-12-01Sell74,668$5.89-9view
Martens JuergenCorporate VP 2014-11-24Sell140,000$6.14-12.7view
Thomson DavidVP & General Counsel 2014-11-24Sell118,114$6.14-12.7view
Martens JuergenCorporate VP 2014-10-31Sell63,800$6.09-11.99view
Martens JuergenCorporate VP 2014-10-03Sell63,800$5.48-2.19view
Martens JuergenCorporate VP 2014-08-27Sell417$7.6-29.47view
Martens JuergenCorporate VP 2014-08-22Sell22,775$7.02-23.65view
Palumbo DianeVice President, Human Resource 2014-08-15Sell18,726$7.01-23.54view
Thomson DavidVP & General Counsel 2014-08-07Sell30,000$8.16-34.31view

Press Releases about MNKD :

    Quarterly/Annual Reports about MNKD:

    News about MNKD:

    Articles On GuruFocus.com
    What to Watch for: November 3-7 Nov 04 2014 
    Roche to Acquire InterMune and Deliver Hope to Patients Worldwide Aug 25 2014 
    How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug Aug 20 2014 
    Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
    Evaluating MannKind (MNKD) & Sanofi (SNY) Agreement for Afrezza Aug 15 2014 
    There is a Tide in the Affairs of MannKind: When Taken At the Flood, Will Lead to Fortune Aug 14 2014 
    What This Upcoming Monday Means For MannKind Shareholders Aug 08 2014 
    Shareholders To Inhale Relief As MannKind Found Its Bright Insulin Supply Partner Amphastar Aug 06 2014 
    Shareholders To Inhale Relief As MannKind Found Its Bright Insulin Supply Partner Amphastar Aug 06 2014 
    Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes Market Jul 29 2014 


    More From Other Websites
    MannKind Sees More Insider Selling Dec 04 2014
    MannKind Corporation to Present at The 26th Annual Piper Jaffray Healthcare Conference Nov 25 2014
    MannKind's Afrezza Remains in Sanofi's Plans, RBC Says Nov 21 2014
    MANNKIND CORP Financials Nov 19 2014
    10-Q for MannKind Corp. Nov 12 2014
    MANNKIND CORP Files SEC form 10-Q, Quarterly Report Nov 10 2014
    Diabetes Analyst: Sanofi CEO's Firing May Spell Trouble for MannKind Afrezza Partnership Nov 04 2014
    [$$] MannKind's Progress Seen More Gradual Nov 04 2014
    MannKind Falls on Missing Q3 Estimates Yet Cuts Loss Y/Y Nov 04 2014
    Mannkind Corp Earnings Call scheduled for 5:00 pm ET today Nov 03 2014
    MANNKIND CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 03 2014
    MannKind Spending Trends See Improvements Nov 03 2014
    MannKind Corporation Reports 2014 Third Quarter Financial Results Nov 03 2014
    MannKind reports 3Q loss Nov 03 2014
    MannKind reports 3Q loss Nov 03 2014
    MannKind Corporation Reports 2014 Third Quarter Financial Results Nov 03 2014
    Q3 2014 MannKind Earnings Release - Time Not Supplied Nov 03 2014
    MannKind Corporation to Hold 2014 Third Quarter Financial Results Conference Call on November 3,... Oct 27 2014
    MannKind Corporation to Hold 2014 Third Quarter Financial Results Conference Call on November 3,... Oct 27 2014
    Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade Oct 20 2014
    MannKind: Goldman Sachs Sees 'Limited Upside' Oct 20 2014
    MannKind (MNKD) Worth Watching: Stock Gains 12.9% Oct 16 2014
    Short Interest in Biotech Becomes Company Specific Oct 10 2014
    MannKind Receives $150 Million Upfront Payment from Sanofi Oct 03 2014
    MannKind Announces Receipt of $150 Million Licensing Upfront Payment Sep 29 2014
    US STOCKS-Wall St extends gains from Friday in broad rally Aug 11 2014
    US STOCKS-Wall St up for second straight session in broad rally Aug 11 2014
    US STOCKS-Wall St up for 2nd day as Ukraine tensions ease Aug 11 2014
    US STOCKS-Futures imply higher open as Ukraine tensions ease Aug 11 2014
    US STOCKS-Futures higher as Ukraine tensions ease Aug 11 2014
    MannKind, Sanofi enter Afrezza deal worth $925M Aug 11 2014
    Sanofi bets on inhaled insulin with MannKind deal Aug 11 2014
    Inhaled insulin to make comeback with Sanofi deal Aug 11 2014
    US STOCKS-S&P 500, Nasdaq set for 6th straight quarter of gains Jun 30 2014
    US STOCKS-S&P 500, Nasdaq set for sixth straight quarter of gains Jun 30 2014
    US STOCKS-Wall St little changed, set to end quarter higher Jun 30 2014
    US STOCKS-Wall St to open flat, quarter set to end positive Jun 30 2014
    US STOCKS-Futures dip modestly, but quarter set to end positive Jun 30 2014
    US STOCKS-S&P 500 ends at another record; data puts jobs in focus Apr 02 2014
    US STOCKS-Wall St edges up after data, S&P 500 holds at record Apr 02 2014
    US STOCKS-Wall St rises modestly after data, holds at record high Apr 02 2014
    Ahead of the Bell: MannKind shares soar Apr 02 2014
    US STOCKS-Wall St to open flat after ADP; factory orders due Apr 02 2014
    US STOCKS-Futures edge higher after record close; ADP on tap Apr 02 2014
    MannKind Corporation to Present at Upcoming Conferences Feb 19 2014
    MannKind Corporation Reports 2013 Fourth Quarter and Full Year Financial Results Feb 18 2014
    MannKind Corporation to Hold 2013 Fourth Quarter and Full Year Financial Results Conference Call on... Feb 04 2014
    MannKind Announces Tentative Date of FDA Advisory Committee Review of AFREZZA Jan 10 2014
    MannKind Corporation to Present at the J.P. Morgan 2014 Healthcare Conference Jan 08 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK